Published in J Clin Invest on July 01, 1994
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A (1995) 2.11
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol (2000) 1.93
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A (1997) 1.46
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol (2001) 1.42
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol (1996) 1.35
Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol (2001) 1.32
Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol (1997) 1.25
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol (2001) 1.11
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol (2000) 1.08
The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. J Virol (2010) 1.02
Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol (2003) 0.99
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol (2002) 0.95
Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology (2012) 0.92
HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int (2013) 0.92
Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res (2008) 0.92
Expression of hepatitis B virus X protein in transgenic mice. World J Gastroenterol (2003) 0.89
Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression. J Virol (2000) 0.89
Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol (2011) 0.82
Viral transformation and aneuploidy. Environ Mol Mutagen (2009) 0.81
Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. Dig Dis Sci (2015) 0.81
Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein. World J Gastroenterol (2006) 0.79
Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol (2004) 0.78
Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma. World J Hepatol (2016) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The hepatitis B virus. Nature (1985) 8.71
Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature (1984) 7.54
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res (1983) 4.94
Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (1984) 4.56
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol (1989) 2.21
Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol (1983) 1.93
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology (1994) 1.74
Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science (1993) 1.69
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene (1988) 1.54
Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science (1985) 1.51
Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology (1993) 1.50
The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res (1989) 1.45
Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol (1990) 1.37
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res (1991) 1.25
Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas. J Virol (1987) 1.21
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun (1991) 1.20
Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.10
In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J Hepatol (1991) 1.06
Transgenic mouse model for human gastric carcinoma. Proc Natl Acad Sci U S A (1989) 1.04
Hepatitis B X-gene expression in hepatocellular carcinoma. J Hepatol (1992) 1.00
Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol (1993) 0.99
Characterization of hepatitis B virus X gene: in vitro translation of mRNA from COS-1 cells transfected with the X gene. Virology (1988) 0.84
Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res (2001) 15.22
Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc (2001) 6.76
Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol (1998) 4.94
Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature (2001) 4.83
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med (1998) 4.48
Diversification of Escherichia coli genomes: are bacteriophages the major contributors? Trends Microbiol (2001) 3.08
Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol (1997) 2.98
Eight calves cloned from somatic cells of a single adult. Science (1998) 2.84
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology (2001) 2.80
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
The initiator function of DnaA protein is negatively regulated by the sliding clamp of the E. coli chromosomal replicase. Cell (1998) 2.50
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A (2001) 2.39
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion (2001) 2.16
In vitro study of illegitimate recombination: involvement of DNA gyrase. Cold Spring Harb Symp Quant Biol (1981) 1.90
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest (1993) 1.85
Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med (1991) 1.80
Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J (2001) 1.74
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology (1994) 1.74
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest (1997) 1.73
Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med (2000) 1.72
Complete nucleotide sequence of the prophage VT2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O157:H7 derived from the Sakai outbreak. Genes Genet Syst (1999) 1.70
Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int (1999) 1.57
Xylitol gum and maternal transmission of mutans streptococci. J Dent Res (2010) 1.56
The serology of chronic hepatitis B infection revisited. J Clin Invest (1993) 1.54
Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther (1999) 1.51
Use of prescribed drugs among older people in Japan: association with not having a regular physician. J Am Geriatr Soc (1999) 1.49
Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int (1999) 1.46
Infectivity of Cryptosporidium muris (strain RN 66) in various laboratory animals. Parasitol Res (1989) 1.46
Effect of mental stress on plasma homovanillic acid in healthy human subjects. Neuropsychopharmacology (1998) 1.45
A diabetic case with hemoglobin J-Meerut and low HbA1C levels. Intern Med (1997) 1.45
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer (1991) 1.45
Involvement of rho in GTP gamma S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett (1995) 1.42
Current status of renal replacement therapy in Japan: results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant (1996) 1.41
Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant (1996) 1.41
Blood hepatocyte growth factor levels in chronic renal failure patients. Nephron (1994) 1.41
Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol (2000) 1.41
L-arginine inhibits neointimal formation following balloon injury. Life Sci (1993) 1.41
Cowden's disease with a defined genetic alteration--chromosomal duplication at 15q11-q13. J Gastroenterol (1997) 1.39
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
Radiotherapy following mastectomy: indication and contraindication of chest wall irradiation. Int J Radiat Oncol Biol Phys (1999) 1.38
Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene (2000) 1.37
Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer (2000) 1.37
Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology (1998) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis (2001) 1.34
Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls. Neuropsychopharmacology (1999) 1.34
Paratracheal air cysts communicating with the trachea: CT findings. J Thorac Imaging (1997) 1.33
Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med (1993) 1.32
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int (2006) 1.30
Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci U S A (1981) 1.29
Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis (1996) 1.28
Clinical evaluation of inferior alveolar nerve block by injection into the pterygomandibular space anterior to the mandibular foramen. Anesth Prog (2000) 1.26
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol (1994) 1.25
Chromosome of the enterohemorrhagic Escherichia coli O157:H7; comparative analysis with K-12 MG1655 revealed the acquisition of a large amount of foreign DNAs. DNA Res (1999) 1.24
Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology (1994) 1.24
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol (1999) 1.24
Apolipoprotein E deficiency with a depressed mRNA of normal size. Atherosclerosis (1991) 1.23
4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J Cell Sci (2000) 1.23
Structure, chromosome location, and expression of the human smooth muscle (enteric type) gamma-actin gene: evolution of six human actin genes. Mol Cell Biol (1991) 1.22
Development of a direct in situ PCR method for detection of specific bacteria in natural environments. Appl Environ Microbiol (1998) 1.20
Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int (2007) 1.19
Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int (1997) 1.18
Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun (1993) 1.17
Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A (1997) 1.15
Medical decisions concerning the end of life: a discussion with Japanese physicians. J Med Ethics (1997) 1.15
Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology (1993) 1.14
4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci (1999) 1.14
Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less. Urology (2001) 1.13
Identification of temperature-sensitive dnaD mutants of Staphylococcus aureus that are defective in chromosomal DNA replication. Mol Genet Genomics (2004) 1.13
Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus. Lancet (1990) 1.12
Effect of PGE2 on vasopressin-dependent cell cAMP in isolated single nephron segments. Am J Physiol (1983) 1.12
Association of the urease gene with enterohemorrhagic Escherichia coli strains irrespective of their serogroups. J Clin Microbiol (2001) 1.11
Calcitonin selectively stimulates 25-hydroxyvitamin D3-1 alpha-hydroxylase in proximal straight tubule of rat kidney. Nature (1981) 1.10
Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron (1998) 1.09
Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commun (1997) 1.09
Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med (2000) 1.09
Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells. J Clin Invest (1986) 1.09
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol (1998) 1.09
Beta-2 microglobulin in renal disease. J Am Soc Nephrol (1998) 1.08
Parathyroid hormone has a positive inotropic action in the rat. Endocrinology (1981) 1.08
Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol (1997) 1.08
Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int (1999) 1.08
Negative control of DNA replication by hydrolysis of ATP bound to DnaA protein, the initiator of chromosomal DNA replication in Escherichia coli. EMBO J (1997) 1.08
Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med (1990) 1.08
The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol (1995) 1.07
Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Gastroenterology (2001) 1.06